NANO LABS LTD (NA)

KYG6391Y1109 - Common Stock

0.592  +0 (+0.75%)

Fundamental Rating

2

NA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 107 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of NA have multiple concerns. NA does not seem to be growing, but still is valued expensively.



3

1. Profitability

1.1 Basic Checks

NA had positive earnings in the past year.

1.2 Ratios

NA has a Return On Assets of 10.48%. This is in the better half of the industry: NA outperforms 77.36% of its industry peers.
With an excellent Return On Equity value of 97.19%, NA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 16.59%, NA belongs to the best of the industry, outperforming 88.68% of the companies in the same industry.
Industry RankSector Rank
ROA 10.48%
ROE 97.19%
ROIC 16.59%
ROA(3y)-24.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 3.16%, NA perfoms like the industry average, outperforming 48.11% of the companies in the same industry.
Looking at the Operating Margin, with a value of 2.11%, NA is in line with its industry, outperforming 46.23% of the companies in the same industry.
NA's Gross Margin of 23.41% is on the low side compared to the rest of the industry. NA is outperformed by 77.36% of its industry peers.
Industry RankSector Rank
OM 2.11%
PM (TTM) 3.16%
GM 23.41%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NA is still creating some value.
The number of shares outstanding for NA has been increased compared to 1 year ago.
NA has a worse debt/assets ratio than last year.

2.2 Solvency

NA has an Altman-Z score of 2.39. This is not the best score and indicates that NA is in the grey zone with still only limited risk for bankruptcy at the moment.
NA has a Altman-Z score of 2.39. This is in the lower half of the industry: NA underperforms 62.26% of its industry peers.
A Debt/Equity ratio of 2.05 is on the high side and indicates that NA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.05, NA is doing worse than 88.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACC1.53
WACC10.85%

2.3 Liquidity

NA has a Current Ratio of 0.70. This is a bad value and indicates that NA is not financially healthy enough and could expect problems in meeting its short term obligations.
NA has a worse Current ratio (0.70) than 95.28% of its industry peers.
A Quick Ratio of 0.49 indicates that NA may have some problems paying its short term obligations.
NA's Quick ratio of 0.49 is on the low side compared to the rest of the industry. NA is outperformed by 93.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.7
Quick Ratio 0.49

2

3. Growth

3.1 Past

NA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.79%, which is quite impressive.
Looking at the last year, NA shows a very strong growth in Revenue. The Revenue has grown by 2395.43%.
EPS 1Y (TTM)117.79%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-216.07%
Revenue 1Y (TTM)2395.43%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2Q-86.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

NA is valuated rather expensively with a Price/Earnings ratio of 19.73.
78.30% of the companies in the same industry are more expensive than NA, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.11, NA is valued a bit cheaper.
Industry RankSector Rank
PE 19.73
Fwd PE N/A

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NA is valued cheaply inside the industry as 83.96% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NANO LABS LTD

NASDAQ:NA (5/8/2024, 10:41:45 AM)

0.592

+0 (+0.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap38.67M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 19.73
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 10.48%
ROE 97.19%
ROCE
ROIC
ROICexc
ROICexgc
OM 2.11%
PM (TTM) 3.16%
GM 23.41%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover3.31
Health
Industry RankSector Rank
Debt/Equity 2.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.7
Quick Ratio 0.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)117.79%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)2395.43%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y